Related Experiment Videos
[Gilbert disease and isotretinoin]
1Centre Hospitalier, Service de Dermatologie, Saint-Germain-en-Laye.
Annales De Dermatologie Et De Venereologie
|January 1, 1997
Summary
Isotretinoin is safe for treating acne in patients with Gilbert's syndrome, a common genetic condition. This acne medication demonstrated good tolerance and even improved bilirubin levels in a case study.
Area of Science:
- Dermatology
- Hepatology
- Clinical Pharmacology
Background:
- Isotretinoin, a retinoid, carries potential hepatotoxicity risks, necessitating cautious prescription, especially in patients with liver conditions.
- Gilbert's syndrome is characterized by chronic, mild, unconjugated hyperbilirubinemia.
- Previous reports suggest isotretinoin is generally well-tolerated in individuals with Gilbert's syndrome.
Observation:
- A 17-year-old male with Gilbert's syndrome and severe nodulocystic acne, unresponsive to other treatments, was prescribed isotretinoin.
- Liver function and bilirubin levels were regularly monitored during isotretinoin therapy.
- A consistent decrease in serum bilirubin was observed during treatment, with a subsequent rise upon dose reduction or discontinuation.
Findings:
- The case study indicates that isotretinoin can be safely administered to patients with Gilbert's syndrome.
- Isotretinoin therapy not only proved tolerable but also led to an improvement in hyperbilirubinemia associated with Gilbert's syndrome.
- Literature review confirms limited hepatotoxicity from isotretinoin, contrasting with etretinate, and supports its safety in Gilbert's syndrome.
Implications:
- Clinicians should consider isotretinoin as a viable and potentially beneficial treatment option for acne in patients diagnosed with Gilbert's syndrome.
- Understanding the safety profile of isotretinoin in this specific patient population can guide therapeutic decisions and improve patient outcomes.
- Further research into the pharmacological mechanisms underlying isotretinoin's effects on bilirubin metabolism in Gilbert's syndrome may yield novel therapeutic insights.